Anti-Inflammatory Signaling
Studied for NF-κB pathway suppression independent of melanocortin receptor activity.
Overview
KPV is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH), studied for anti-inflammatory activity that appears largely independent of melanocortin receptor activation. Its small size allows efficient cell-membrane penetration to modulate intracellular inflammatory signaling.
Suria's KPV is synthesized to high purity and independently verified prior to release, supporting consistent results across inflammatory signaling and tissue-repair research models.
Research Use Only. Not for human or veterinary use.
Specifications
Third-Party Testing
Available third-party analytical documentation for KPV can be reviewed for applicable batches through Suria's Batch Documentation system. We believe documentation should be held to the same standard as the research it supports.
Certificates of Analysis will be available at time of launch.
Research Highlights
Studied for NF-κB pathway suppression independent of melanocortin receptor activity.
Examined in wound-healing and mucosal-inflammation research models.
A compact tripeptide structure that readily penetrates cell membranes.
Referenced across two decades of inflammatory-pathway research.
Storage
Store as specified above, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the recommended window for your protocol.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation